🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This clinical trial is a study to evaluate the safety, tolerability, and ch...
Status
Terminated
Location
Radboud University Medical Center
Start Date
2019-08-23
Trial ID
NCT04004000
Treatments Being Tested
This is a study to evaluate the safety and efficacy of Losmapimod in treati...
Status
Completed
Location
University of California Irvine
Start Date
2019-08-09
Trial ID
NCT04003974
Treatments Being Tested
This is a study to evaluate the safety and efficacy of losmapimod in treati...
Status
Terminated
Location
University of California Irvine
Start Date
2022-06-16
Trial ID
NCT05397470
Treatments Being Tested
The therapeutic hypothesis for the use of losmapimod in COVID-19 disease is...
Status
Terminated
Location
University of California Irvine - Irvine Medical Center
Start Date
2020-08-28
Trial ID
NCT04511819
Treatments Being Tested
This is a randomised, double-blind, parallel-group, multi-centre study eval...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-12-09
Trial ID
NCT02299375
Treatments Being Tested
The purpose of this study is to evaluate the safety of an IV infusion of GW...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-02-02
Trial ID
NCT01039961
Treatments Being Tested
This study is an open-label extension to evaluate the safety and tolerabili...
Status
Terminated
Location
University of California Irvine
Start Date
2020-02-13
Trial ID
NCT04264442
Treatments Being Tested
Randomised, double-blind, parallel-group, multi-centre study evaluating thr...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-11-04
Trial ID
NCT01218126
Treatments Being Tested
This is a study to assess the relative bioavailability and the effect of fo...
Status
Completed
Location
PPD Phase I Clinic
Start Date
2021-08-19
Trial ID
NCT05002231
This is a single-arm, multicenter, open-label Phase II, proof-of-mechanism ...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-07-01
Trial ID
NCT02000440
Treatments Being Tested